What does this research mean for the field?

First-line therapy yields a more pronounced therapeutic response and higher success rate in patients with venogenic erectile dysfunction compared to those with metabolic syndrome-induced erectile dysfunction. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

This study aims to compare treatment outcomes for erectile dysfunction caused by metabolic syndrome and venogenic dysfunction.

June 6, 2026The Journal of Sexual Medicine

(611) Comparative Analysis of the Complex/Combined Treatment for 60 Men With Erectile Dysfunction Due to Metabolic Syndrome and Venogenic Dysfunction: An Evidence - Based Study

View Full Paper

Ask AI

Bookmark

Authors

ZMZ Marshania NNN Nodia

Discussion

Member takes

Overview

Evidence-based study compares treatment outcomes for metabolic syndrome and venogenic erectile dysfunction.

Key Points

This study aims to compare treatment outcomes for erectile dysfunction caused by metabolic syndrome and venogenic dysfunction.
Included 60 male patients diagnosed with erectile dysfunction, divided into two groups (30 with metabolic syndrome, 30 with venogenic dysfunction).
Evaluated testosterone levels, lipid profiles, and erectile function using the IIEF-5 questionnaire.
Applied different treatment regimens: aphrodisiacs and PDE-5 inhibitors for metabolic syndrome; venotonics and PDE-5 inhibitors for venogenic dysfunction.
87% of patients with metabolic syndrome reported improvement after treatment, compared to 97% in the venogenic dysfunction group.
Testosterone levels significantly increased for both groups after treatment, with P = 0.022 for metabolic syndrome and P = 0.001 for venogenic dysfunction.
A strong correlation (P < 0.001) between pre- and post-treatment testosterone levels was observed, indicating a more pronounced response in the venogenic dysfunction group.

Cite This Study

Marshania et al. (2026) studied this question.

synapsesocial.com/papers/6a23bb7971a5da9775e76e62 https://doi.org/10.1093/jsxmed/qdag118.539

View Full Paper

Ask AI

Bookmark

June 6, 2026The Journal of Sexual Medicine

(611) Comparative Analysis of the Complex/Combined Treatment for 60 Men With Erectile Dysfunction Due to Metabolic Syndrome and Venogenic Dysfunction: An Evidence - Based Study

View Full Paper

Ask AI

Bookmark

Authors

ZMZ Marshania NNN Nodia

Discussion

Member takes

Overview

Evidence-based study compares treatment outcomes for metabolic syndrome and venogenic erectile dysfunction.

Key Points

This study aims to compare treatment outcomes for erectile dysfunction caused by metabolic syndrome and venogenic dysfunction.
Included 60 male patients diagnosed with erectile dysfunction, divided into two groups (30 with metabolic syndrome, 30 with venogenic dysfunction).
Evaluated testosterone levels, lipid profiles, and erectile function using the IIEF-5 questionnaire.
Applied different treatment regimens: aphrodisiacs and PDE-5 inhibitors for metabolic syndrome; venotonics and PDE-5 inhibitors for venogenic dysfunction.
87% of patients with metabolic syndrome reported improvement after treatment, compared to 97% in the venogenic dysfunction group.
Testosterone levels significantly increased for both groups after treatment, with P = 0.022 for metabolic syndrome and P = 0.001 for venogenic dysfunction.
A strong correlation (P < 0.001) between pre- and post-treatment testosterone levels was observed, indicating a more pronounced response in the venogenic dysfunction group.

Cite This Study

Marshania et al. (2026) studied this question.

synapsesocial.com/papers/6a23bb7971a5da9775e76e62 https://doi.org/10.1093/jsxmed/qdag118.539

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark